Agency For Medical Innovations India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 12-07-2024
- Paid Up Capital ₹ 0.10 M
as on 12-07-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 64.47%
(FY 2017)
- Profit 181.70%
(FY 2017)
- Ebitda 76.54%
(FY 2017)
- Net Worth 51.09%
(FY 2017)
- Total Assets -21.27%
(FY 2017)
About Agency For Medical Innovations India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Safeena Charriyat, Haresh Masand, Shafeeq Ambalapurath, and One other member serve as directors at the Company.
- CIN/LLPIN
U29220MH2007PTC170270
- Company No.
170270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Agency For Medical Innovations India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Haresh Masand  | Director | 24-Apr-2007 | Current |
| Safeena Charriyat | Director | 17-Dec-2010 | Current |
| Shafeeq Ambalapurath | Director | 24-Apr-2007 | Current |
| Biharilal Lakhmichand | Director | 24-Apr-2007 | Current |
Financial Performance of Agency For Medical Innovations India.
Agency For Medical Innovations India Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 64.47% increase. The company also saw a substantial improvement in profitability, with a 181.7% increase in profit. The company's net worth Soared by an impressive increase of 51.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agency For Medical Innovations India?
In 2017, Agency For Medical Innovations India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Harrison Medical Instruments Company Private LimitedActive 22 years 8 monthsHaresh Masand is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Agency For Medical Innovations India?
Unlock and access historical data on people associated with Agency For Medical Innovations India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agency For Medical Innovations India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agency For Medical Innovations India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
